Crossmark

Assessing the efficacy of combined treatment using bedaquiline against clinical isolates of multidrug-resistant Mycobacterium tuberculosis in vitro and the macrophage model

Crossref DOI link: https://doi.org/10.1186/s12866-026-04853-8

Published Online: 2026-02-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ahmadi, Kamal

Madadi-Goli, Nahid

Azizi, Mohsen

Hadifar, Shima

Ebrahimzadeh, Nayereh

Masoumi, Morteza

Nasehi, Mahshid

Siadat, Seyed Davar

Fateh, Abolfazl

Vaziri, Farzam
License Information

Text and Data Mining valid from 2026-02-26

Version of Record valid from 2026-04-01
More Information

Article History

Received: 27 November 2024

Accepted: 11 February 2026

First Online: 26 February 2026

Declarations

:

: This study was conducted in accordance with the principles of the Declaration of Helsinki. The study was approved by the Ethics Committee of the Pasteur Institute of Iran (IR.PII.REC.1399.054), and written informed consent was obtained from all participants.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below